BERGEM·HEALTH
Free consultation
Home › Doctors › Prof. MD. Mehmet Hilmi Doğu
HEMATOLOGY · LIV ULUS

Prof. MD. Mehmet Hilmi Doğu

Professor of Hematology · Liv Hospital Ulus
Prof. Dr. Mehmet Hilmi Doğu is a hematologist at Liv Hospital Ulus and Liv Hospital Bahçeşehir. After earning his MD at Ege University and completing internal medicine and hematology training at Pamukkale University, he served at Istanbul Training and Research Hospital as Associate Professor and at Başakşehir Çam ve Sakura City Hospital. His clinical and research focus is chronic leukemia (CLL/CML), myeloproliferative neoplasms, lymphoma and multiple myeloma, with active board membership in the Society of Hematological Education and Research.
15+
years in internal medicine
10+
years in hematology
50+
peer-reviewed publications
Chronic LeukemiaCLLCMLLymphomaMultiple MyelomaMyeloproliferative DiseaseApheresis
A BergemHealth coordinator arranges contact with the professor within 24–48 hours on business days.
Direct contract with BergemHealth
CONSULTATION LANGUAGES
TR Turkish · native
EN English · professional
RU Russian · via BergemHealth coordinator
UK Ukrainian · via BergemHealth coordinator
ISTANBUL · 05/2026
AWARDS & RECOGNITION
  • ★
    2013
    Young Researcher Award
    n/a (Liv profile mentions 'Your Researcher Award' likely OCR error for 'Young Researcher')
  • 2013-2016
    Apheresis and Hematologic Oncology Recognition Awards
    various Turkish hematology bodies
EDUCATION & CAREER

Timeline

Career milestones.

2011
Internal Medicine Specialist
Denizli Sarayköy State Hospital
2011-2016
Internal Medicine / Hematology training
Pamukkale University
2015
Hematology Specialist
Selçuk University Faculty of Medicine Hospital
2015-2020
Hematology Specialist / Section Head
Istanbul Training and Research Hospital
2020
Lecturer / Faculty
Istanbul Başakşehir Çam ve Sakura City Hospital
current
Professor of Hematology
Liv Hospital Ulus / Liv Hospital Bahçeşehir
PUBLICATIONS

Scientific work

Selected peer-reviewed publications.

  • 2021
    J Med Virol
    «The outcome of COVID-19 in patients with hematological malignancy»
    · co-author · 156 citations
  • 2020
    Ann Hematol
    «Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience»
    · co-author · 98 citations
  • 2021
    Transfus Apher Sci
    «Convalescent plasma therapy in patients with COVID-19»
    · co-author · 90 citations
  • 2013
    Transfus Apher Sci
    «Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis»
    · co-author · 77 citations
  • 2020
    J Oncol Pharm Pract
    «Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors»
    · co-author · 42 citations
  • 2021
    Bone Marrow Transplant
    «COVID-19 in hematopoietic cell transplant recipients»
    · co-author · 38 citations
CLINIC

Where they practise

Direct contract with BergemHealth at every listed clinic.

PRIMARY CLINIC
Liv Hospital Ulus
The flagship hospital of the Liv Hospital group in the upscale Ulus district. JCI accreditation and the first SRC certificate in robotic surgery outside the United States. 60+ departments, three…
Open clinic profile
REQUEST

Tell me about your case — I’ll read it personally.

Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.

Open the consultation form
  • Reply within 4 hours during business hours
  • Confidentiality guaranteed
  • Coordinator-translator inside the doctor’s office
  • Tumour board of 2–3 professors within 72 hours
OTHER DOCTORS

Similar BergemHealth professors

Adjacent specialties and second opinions. Direct contracts, verified cases.

Prof. Dr. Selda Korkmaz Yakar, MD
Professor profile
Doç. Dr. Ebru Özan Sanhal
Professor profile
Prof. Dr. Gülen Bülbül Doğusoy, MD
Professor profile